HIV/AIDS Therapy
Investigators at Center for AIDS Research have published new data on HIV/AIDS therapy
Published in AIDS Weekly, June 11th, 2007
New investigation results, "A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India," are detailed in a study published in AIDS Care. "This randomised control trial, conducted in Chennai, India, compared structured interrupted therapy (SIT) and continuous therapy (CT) in relation to immunologic and virologic outcomes, adverse events (AEs) and cost of therapy. ART-naïve adult HIV1-infected participants with CD4 counts 50-350 cells/mm(3), and plasma viral load (PVL) >5000 copies/mL were enrolled and placed on Indian-manufactured generic ART:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-06-11)
More Articles from AIDS Weekly
- HIV/AIDS
New Study Suggests Potential for a Broadly-Protective HIV Vaccine - HIV/AIDS
Treating HIV in war zones -- Public health emergencies need rapid advice from WHO - HIV/AIDS Co-Infection
Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths - HIV/AIDS
Activists to Crist: 'Be the Governor for People with AIDS,' Says AHF - HIV/AIDS
Avexa Wins $4.3m Commercial Ready Grant for Anti-HIV Drug Discovery Program - HIV/AIDS
Bush AIDS Proposal an Important Step, but not a Doubling of Current Funding - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
